...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
AGORACOM NEWS FLASH

BREAKING: Loop Insights Announces Reseller Partnership And First Sale With Vend, A Global POS Company Used In 25,000 Stores Across 140 Countries

  • Announced the signing of a channel reseller partnership with global cloud-based Point-of-Sale (POS) company, Vend, as well as, the first sale to a Vend client
  • Vend is the first POS built for iOS and is now used in over 25,000 stores across 140 countries
  • Vend’s fast growth and global reach creates opportunities across the world for Loop and its technology in the retail vertical

Loop large

Hub On AGORACOM / Read Release

 

Message: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019

Good Endpoints article on Biogen.

https://endpts.com/analyst-brian-skorney-goes-grizzly-on-biogens-alzheimers-hype-fearmongering-and-statistical-malpractice/

Also, forgive my perpetuation of confusion. Biogen's Aducanumab and BAN2401 are two separate drugs that both tackle amyloid. I previously implied that they were one and the same.

BearDownAZ

Share
New Message
Please login to post a reply